Scioderm, Inc.'s co-founder and CEO Robert Ryan, PhD was appointed to the board of directors of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA). DebRA is the only national non-profit group dedicated to funding research and providing services and programs for those with epidermolysis bullosa (EB). Scioderm's lead program is an investigational therapy being evaluated for the treatment of skin blistering and erosions associated with EB, including facilitation of healing of skin lesions and reduction of the incidence and/or severity of new lesions.

"I am excited that Robert is joining the Debra of America Board of Directors," said Executive Director, Brett Kopelan, in a press release. "Robert brings a wealth of experience to the Board and this will prove strategically invaluable for the organization.  Furthermore Robert brings with him a great personal passion for the cause that I have no doubt will energize those around him on the Board."

"I am honored to be appointed to the board of a non-profit group dedicated to help find a cure for EB," said Dr. Ryan. "I am looking forward to being an active board member and working with the DebRA organization towards raising awareness of the disease and raising funds to support research and the families with EB."